Crescent R&D Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
- Paid Up Capital ₹ 7.50 Cr
- Company Age 10 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 40.75 Cr
- Revenue Growth 14.45%
- Profit Growth -268.34%
- Ebitda -63.48%
- Net Worth -14.46%
- Total Assets 10.17%
About Crescent R&D
Crescent R&D Private Limited (CRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 July 2014 and has a history of Ten years and seven months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 7.50 Cr.
The company has closed loans amounting to ₹40.75 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mohammed Aldoori, Laith Aldoori, Samie Aldoori, and One other member serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900TN2014PTC096380
-
Company No.
096380
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Jul 2014
-
Date of AGM
20 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Crescent R&D Private Limited offer?
Crescent R&D Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at Crescent R&D?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammed Aldoori
|
Director | 10-May-2023 | Current |
|
Laith Aldoori
|
Director | 10-May-2023 | Current |
|
Samie Aldoori
|
Director | 10-May-2023 | Current |
Duraisamy Palani
|
Director | 28-Apr-2021 | Current |
Financial Performance of Crescent R&D.
Archimedis Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.45% increase. The company also saw a substantial fall in profitability, with a 268.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crescent R&D?
In 2022, Crescent R&D had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Archimedis Digital Private LimitedDuraisamy Palani is a mutual person
-
S Zhaveri Pharmakem Private LimitedMohammed Al-Doori, Laith Aldoori and 1 more are mutual person
Charges (Loans)
₹0
₹40.75 Cr
Charges Breakdown by Lending Institutions
- Bank Of India : 22.09 Cr
- Axis Bank Limited : 14.57 Cr
- Sidbi : 4.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Aug 2020 | Sidbi | ₹1.45 M | Satisfied |
| 18 Dec 2019 | Sidbi | ₹3.94 Cr | Satisfied |
| 16 Jul 2016 | Axis Bank Limited | ₹14.57 Cr | Satisfied |
| 30 Aug 2014 | Bank Of India | ₹17.09 Cr | Satisfied |
| 28 Aug 2014 | Bank Of India | ₹5.00 Cr | Satisfied |
How Many Employees Work at Crescent R&D?
Crescent R&D has a workforce of 98 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crescent R&D, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crescent R&D's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
